271. 強直性脊椎炎 Ankylosing spondylitis Clinical trials / Disease details

臨床試験数 : 574 / 薬物数 : 359 - (DrugBank : 68) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 146

16 trials found

diseases per page:

Showing 1 to 10 of 16 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2011-001555-37-EE (EUCTR)	19/04/2013	19/03/2013	Phase 3 study to evaluate safety and effectiveness of oral Apremilast(CC-10004) in patients with ank ...	A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalua ...	Ankylosing spondylitis (AS) MedDRA version: 18.1;Level: PT;Classification code 10002556;Term: Ankylo ...	Product Name: Apremilast Product Code: CC -10004 INN or Proposed INN: Apremilast Product Name: Apremilas ...	Celgene Corporation	NULL	Not Recruiting			Female: yes Male: yes	456	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Estonia;Slovakia;Spain;Austria;Russian Federation;United Kingdom;France;Hungary;Czech ...
2	EUCTR2011-001555-37-NL (EUCTR)	05/12/2012	15/05/2012	Phase 3 study to evaluate safety and effectiveness of oral Apremilast(CC-10004) in patients with ank ...	A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalua ...	Ankylosing spondylitis (AS) MedDRA version: 14.1;Level: PT;Classification code 10002556;Term: Ankylo ...	Product Name: Apremilast Product Code: CC -10004 INN or Proposed INN: Apremilast Product Name: Apremilas ...	Celgene Corporation	NULL	Not Recruiting			Female: yes Male: yes	456	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Estonia;Slovakia;Spain;Austria;Russian Federation;United Kingdom;France;Hungary;Czech ...
3	EUCTR2011-001555-37-BG (EUCTR)	14/11/2012	14/08/2012	Phase 3 study to evaluate safety and effectiveness of oral Apremilast(CC-10004) in patients with ank ...	A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalua ...	Ankylosing spondylitis (AS) MedDRA version: 20.0;Level: PT;Classification code 10002556;Term: Ankylo ...	Product Name: Apremilast Product Code: CC -10004 INN or Proposed INN: Apremilast Product Name: Apremilas ...	Celgene Corporation	NULL	Not Recruiting			Female: yes Male: yes	456	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Estonia;Slovakia;Spain;Austria;Russian Federation;United Kingdom;France;Hungary;Czech ...
4	EUCTR2011-001555-37-DE (EUCTR)	20/09/2012	08/05/2012	Phase 3 study to evaluate safety and effectiveness of oral Apremilast(CC-10004) in patients with ank ...	A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalua ...	Ankylosing spondylitis (AS) MedDRA version: 18.0;Level: PT;Classification code 10002556;Term: Ankylo ...	Product Name: Apremilast Product Code: CC -10004 INN or Proposed INN: Apremilast Product Name: Apremilas ...	Celgene Corporation	NULL	Not Recruiting			Female: yes Male: yes	456	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Estonia;Slovakia;Spain;Austria;Russian Federation;United Kingdom;France;Hungary;Czech ...
5	EUCTR2011-001555-37-GB (EUCTR)	04/09/2012	16/04/2012	Phase 3 study to evaluate safety and effectiveness of oral Apremilast(CC-10004) in patients with ank ...	A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalua ...	Ankylosing spondylitis (AS) MedDRA version: 20.0;Level: PT;Classification code 10002556;Term: Ankylo ...	Product Name: Apremilast Product Code: CC -10004 INN or Proposed INN: Apremilast Product Name: Apremilas ...	Celgene Corporation	NULL	Not Recruiting			Female: yes Male: yes	456	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Estonia;Slovakia;Spain;Austria;Russian Federation;United Kingdom;France;Hungary;Czech ...
6	EUCTR2011-001555-37-CZ (EUCTR)	14/08/2012	30/05/2012	Phase 3 study to evaluate safety and effectiveness of oral Apremilast(CC-10004) in patients with ank ...	A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalua ...	Ankylosing spondylitis (AS) MedDRA version: 19.0;Level: PT;Classification code 10002556;Term: Ankylo ...	Product Name: Apremilast Product Code: CC -10004 INN or Proposed INN: Apremilast Product Name: Apremilas ...	Celgene Corporation	NULL	Not Recruiting			Female: yes Male: yes	456	Phase 3	United States;Estonia;Slovakia;Spain;Austria;Russian Federation;United Kingdom;France;Hungary;Czech ...
7	EUCTR2011-001555-37-SE (EUCTR)	09/08/2012	29/05/2012	Phase 3 study to evaluate safety and effectiveness of oral Apremilast(CC-10004) in patients with ank ...	A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalua ...	Ankylosing spondylitis (AS) MedDRA version: 19.0;Level: PT;Classification code 10002556;Term: Ankylo ...	Product Name: Apremilast Product Code: CC -10004 INN or Proposed INN: Apremilast Product Name: Apremilas ...	Celgene Corporation	NULL	Not Recruiting			Female: yes Male: yes	456	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Estonia;Slovakia;Spain;Austria;Russian Federation;United Kingdom;France;Hungary;Czech ...
8	EUCTR2011-001555-37-SK (EUCTR)	31/07/2012	15/05/2012	Phase 3 study to evaluate safety and effectiveness of oral Apremilast(CC-10004) in patients with ank ...	A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalua ...	Ankylosing spondylitis (AS) MedDRA version: 14.1;Level: PT;Classification code 10002556;Term: Ankylo ...	Product Name: Apremilast Product Code: CC -10004 INN or Proposed INN: Apremilast Product Name: Apremilas ...	Celgene Corporation	NULL	Not Recruiting			Female: yes Male: yes	456	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Estonia;Slovakia;Spain;Austria;Russian Federation;United Kingdom;France;Hungary;Czech ...
9	EUCTR2011-001555-37-ES (EUCTR)	23/07/2012	28/05/2012	Phase 3 study to evaluate safety and effectiveness of oral Apremilast(CC-10004) in patients with ank ...	A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalua ...	Ankylosing spondylitis (AS) MedDRA version: 14.1;Level: PT;Classification code 10002556;Term: Ankylo ...	Product Name: Apremilast Product Code: CC -10004 INN or Proposed INN: Apremilast Product Name: Apremilas ...	Celgene Corporation	NULL	Not Recruiting			Female: yes Male: yes	456	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Estonia;Slovakia;Spain;Austria;Russian Federation;United Kingdom;France;Hungary;Czech ...
10	EUCTR2011-001555-37-AT (EUCTR)	03/07/2012	30/05/2012	Phase 3 study to evaluate safety and effectiveness of oral Apremilast(CC-10004) in patients with ank ...	A phase 3, multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evalua ...	Ankylosing spondylitis (AS) MedDRA version: 19.0;Level: PT;Classification code 10002556;Term: Ankylo ...	Product Name: Apremilast Product Code: CC -10004 INN or Proposed INN: Apremilast Product Name: Apremilas ...	Celgene Corporation	NULL	Not Recruiting			Female: yes Male: yes	456	Phase 3	United States;Estonia;Slovakia;Spain;Austria;Russian Federation;United Kingdom;France;Hungary;Czech ...

First Previous1 2Next Last